A study led by Dr. Minh Le investigates the potential in red blood cell extracellular vesicles (RBCEVs) to suppress cancer progression. The study recently demonstrated the capabilities of these nano-sized vesicles with successful delivery of immunotherapeutic RNA molecules to suppress cancer growth and metastasis in laboratory models. In addition, the study highlighted the advantages of the RBCEV platform, efficient delivery of therapeutics and potential for engineering specificity to target a variety of cancer types. The team continues its research in hopes to broaden the platform to more cancer types and benefit cancer patients.

Recommended Posts